{BLR 2470} Acorda - Activated Cell Therapy - Alferon - American Red Cross - Amgen - Anti-Infective Agents - BioImmune Systems - Cancer - Chiral Drugs - ChiRex - Cholestech - Colon Cancer - Columbia University - CyberChemics - Cyclins - Duke University - Elan Corp. - EntreMed - Factor IXa Inhibitor - Fampridine - First Medical - FISH - Gene Therapy - Geron - Harvard Medical School - Health Management Systems - Hepatitis C - ICOS - Interferon Sciences - Interneuron - Kinetic Resolution Technology - Leptin - Mabs - Memorial Sloan- Kettering - Pharmacia & Upjohn - Platelet-Activating Factor - ProScript - Purdue Pharma - Sequana Therapeutics - Spinal Cord Injury - Structural Bioinformatics - Suntory - Telomerase - Terrapin - Thrombolysis - University of Arizona - University of Chicago - Varian - VIMRx - Vysis - Wal-Mart - Walter Reed Army Institute

Zdroj:	Biotechnology Law Report; July 1997, Vol. 16 Issue: 4 p481-484, 4p
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu